Biocontainment Unit Renovation & Construction

MARKET RESEARCH PURPOSES ONLY

NOT A REQUEST FOR PROPOSAL OR SOLICITATION

 

This is a Sources Sought notice to determine the availability of Small Businesses capable of supplying the required supply item/services.  This notice is for planning purposes only, and does not constitute an invitation for Bids, Request for Proposal or Request for Quotation or an indication the Government to award a contract, nor does the Government intend to pay for any information submitted as a result of this notice.  Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible.

 

The appropriate NAICS code for the acquisition is 339999 -- All Other Miscellaneous Manufacturing; Small Business Size standards 500 employees million.

 

Background:

 

The Food and Drug Administration ( FDA), Center for Biologics Evaluation and Research (CBER), Laboratory of Respiratory and Special Pathogens, studies the transmission of Bordetella pertussis disease in non-human primates (NHPs).  These animals become highly infectious and require containment housing for several weeks.  CBER currently operates two biocontainment units in the CBER vivarium but will begin utilizing taller NHP cages that require biocontainment units with higher ceilings and doorways. In addition, CBER is expanding the program and will occupy a third room in the CBER Vivarium on the White Oak campus in Silver Spring, MD. 

 

Statement of Need:

 

Therefore, CBER requires the renovation of the two existing biocontainment units and the manufacture and installation of one new Biocontainment Units for studies to be conducted at FDA/CBER Facility in Silver Spring, Maryland.

 

Requirements:

 

The contractor shall renovate two existing negative pressure biocontainment units to increase the height of the units to 7 feet, 7 inches.

 

The contractor shall construct a 21’ x 11.5’ x 7.7’ negative pressure biocontainment unit with 241.5 sq. ft. of unobstructed floor space.

 

The containment environment shall:

• 
  
• Shall allow for a controlled environment (airflow, humidity, and temperature) .
  
• Shall be configured with “freestanding” units (portable, easily assembled, and easily decontaminated).
  
• Shall be made of clear hospital grade vinyl.
  
• Shall be under negative pressure when fully assembled.
  
• Shall maintain at least 50 air changes per hour.
  
• Shall maintain an air velocity of 15-30 feet per minute.
  
• Shall have HEPA filtered exhaust.
  
• Shall not generate noise above 65dB.
  
• Shall have sealed bearings on supply blower.
  
• Shall be delivered 30 – 60 days after receipt of purchase order.
  
• Shall include a one (1) year unlimited warrant.
  

 

FOB Destination:

 

U.S. Food and Drug Administration

White Oak Campus

10903 New Hampshire Avenue

Bldg. 72, CBER Vivarium 

Silver Spring, MD 20993

 

Responses to this sources sought shall unequivocally demonstrate the respondent is regularly engaged in providing Negative-pressure Biocontainment Units. Though the target audience is small business or small businesses capable of providing baboons from another small business, all interested parties may respond. At a minimum, responses shall include the following:

 

1.     Business name and bio, DUNS number, business address, business website, business size status (i.e., SB, VOSB, SDVOSB, HUBZone SB, SDB, WOSB, LB), point of contact name, mailing address (if different from business address), phone number and email address. Provide this same information again if responding to provide a service offered by another firm.

2.     Past Performance information shall include date of services, description, dollar value, client name, Client address, client contact name, client point of contact mailing address (if different from that provided for client), client point of contact phone number, client point of contact email address, and name of company (to include DUNS number and size status) if not the respondent.

3.     Descriptive literature, brochures, marketing material, etc. detailing the nature of services the responding firm is regularly engaged in providing.

4.     If applicable, identification of the firm's GSA Schedule contract(s) by Schedule number and SINs that are applicable to this potential requirement are also requested. If a large business, provide if subcontracting opportunities exist for small business concerns. The Government is not responsible for locating or securing any information, not identified in the response.

 

Interested parties shall  respond with capability statements in person, by e-mail, fax, mail or other delivery method before 12:00 pm (Central Standard Time - Local Prevailing Time in Jefferson, Arkansas) on March 27, 2017 to jennifer.johnson3@fda.hhs.gov, Fax (870) 543-7990, or mail to the U. S. Food and Drug Administration, OO/OFBA/OAGS/DAP, Attention of Jennifer L. Johnson, 3900 NCTR Road, Building 50, Room 429, Jefferson, AR 72079-9502 and Reference: FDA1180610.

 

Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre‐solicitation synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation.

 

Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non‐proprietary technical information in any resultant solicitation(s).